These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32022845)

  • 21. Concurrent hypermulticolor monitoring of CD31, CD34, CD45 and CD146 endothelial progenitor cell markers for acute myocardial infarction.
    Shim Y; Nam MH; Hyuk SW; Yoon SY; Song JM
    Anal Chim Acta; 2015 Jan; 853():501-507. PubMed ID: 25467496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical impact of circulating CD34-positive cells on bone regeneration and healing.
    Kuroda R; Matsumoto T; Kawakami Y; Fukui T; Mifune Y; Kurosaka M
    Tissue Eng Part B Rev; 2014 Jun; 20(3):190-9. PubMed ID: 24372338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of cardiac lymphangiogenesis by transplantation of CD34
    Zhang HF; Wang YL; Tan YZ; Wang HJ; Tao P; Zhou P
    Basic Res Cardiol; 2019 Oct; 114(6):43. PubMed ID: 31587086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD133 allows elaborated discrimination and quantification of haematopoietic progenitor subsets in human haematopoietic stem cell transplants.
    Radtke S; Görgens A; Kordelas L; Schmidt M; Kimmig KR; Köninger A; Horn PA; Giebel B
    Br J Haematol; 2015 Jun; 169(6):868-78. PubMed ID: 25819405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aging impairs long-term hematopoietic regeneration after autologous stem cell transplantation.
    Woolthuis CM; Mariani N; Verkaik-Schakel RN; Brouwers-Vos AZ; Schuringa JJ; Vellenga E; de Wolf JT; Huls G
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):865-71. PubMed ID: 24607555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CXCR4 expression on transplanted peripheral blood CD34+ cells: relationship to engraftment after autologous transplantation in a cohort of multiple myeloma patients.
    Hicks C; Isaacs A; Wong R; Chong BH
    Ann Hematol; 2011 May; 90(5):547-55. PubMed ID: 20957366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Systematic Review of CD34+ Stem Cell Therapy as an Innovative and Efficient Treatment for the Management of Refractory Angina.
    Vithani V; Sutariya B; Montenegro DM; Chukwu M; Ehsan P; Aburumman RN; Muthanna SI; Menon SR; Penumetcha SS
    Cureus; 2022 Dec; 14(12):e32665. PubMed ID: 36660500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Five-Year Clinical and Angiographic Follow-Up Outcomes of Intracoronary Transfusion of Circulation-Derived CD34+ Cells for Patients With End-Stage Diffuse Coronary Artery Disease Unsuitable for Coronary Intervention-Phase I Clinical Trial.
    Sung PH; Lee FY; Tong MS; Chiang JY; Pei SN; Ma MC; Li YC; Chen YL; Wu CJ; Sheu JJ; Lee MS; Yip HK
    Crit Care Med; 2018 May; 46(5):e411-e418. PubMed ID: 29465434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential increase of CD34, KDR/CD34, CD133/CD34 and CD117/CD34 positive cells in peripheral blood of patients with acute myocardial infarction.
    Grundmann F; Scheid C; Braun D; Zobel C; Reuter H; Schwinger RH; Müller-Ehmsen J
    Clin Res Cardiol; 2007 Sep; 96(9):621-7. PubMed ID: 17676354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesenchymal stem cells support expansion of in vitro irradiated CD34(+) cells in the presence of SCF, FLT3 ligand, TPO and IL3: potential application to autologous cell therapy in accidentally irradiated victims.
    Mourcin F; Grenier N; Mayol JF; Lataillade JJ; Sotto JJ; Hérodin F; Drouet M
    Radiat Res; 2005 Jul; 164(1):1-9. PubMed ID: 15966759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of age, disease state, and granulocyte colony-stimulating factor on progenitor cell count and function in patients undergoing cell therapy for cardiac disease.
    Mozid AM; Jones D; Arnous S; Saunders N; Wragg A; Martin J; Agrawal S; Mathur A
    Stem Cells Dev; 2013 Jan; 22(2):216-23. PubMed ID: 22834565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors influencing spontaneous mobilization of CD34+ and CD133+ progenitor cells after myocardial infarction.
    Turan RG; Brehm M; Koestering M; Tobias Z; Bartsch T; Steiner S; Picard F; Ebner P; Schannwell CM; Strauer BE
    Eur J Clin Invest; 2007 Nov; 37(11):842-51. PubMed ID: 17973780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of Nitric Oxide Synthase Restores Circulating Angiogenic Cell Function in Patients With Coronary Artery Disease: Implications for Autologous Cell Therapy for Myocardial Infarction.
    Chen Q; Varga M; Wang X; Haddad DJ; An S; Medzikovic L; Derakhshandeh R; Kostyushev DS; Zhang Y; Clifford BT; Luu E; Danforth OM; Rafikov R; Gong W; Black SM; Suchkov SV; Fineman JR; Heiss C; Aschbacher K; Yeghiazarians Y; Springer ML
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26738788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of ex vivo expanded CD34
    Zhang Y; Shen B; Guan X; Qin M; Ren Z; Ma Y; Dai W; Ding X; Jiang Y
    Stem Cell Res Ther; 2019 Jun; 10(1):173. PubMed ID: 31196160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human hematopoietic stem/progenitor-enriched CD34(+) cells are mobilized into peripheral blood during stress related to ischemic stroke or acute myocardial infarction.
    Paczkowska E; Larysz B; Rzeuski R; Karbicka A; Jałowiński R; Kornacewicz-Jach Z; Ratajczak MZ; Machaliński B
    Eur J Haematol; 2005 Dec; 75(6):461-7. PubMed ID: 16313257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiogenic CD34 Stem Cell Therapy in Coronary Microvascular Repair-A Systematic Review.
    Rai B; Shukla J; Henry TD; Quesada O
    Cells; 2021 May; 10(5):. PubMed ID: 34066713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic Angiogenesis Using Autologous CD34-Positive Cells for Vascular Diseases.
    Fujita Y; Kawamoto A
    Ann Vasc Dis; 2022 Dec; 15(4):241-252. PubMed ID: 36644256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW study.
    Povsic TJ; Junge C; Nada A; Schatz RA; Harrington RA; Davidson CJ; Fortuin FD; Kereiakes DJ; Mendelsohn FO; Sherman W; Schaer GL; White CJ; Stewart D; Story K; Losordo DW; Henry TD
    Am Heart J; 2013 Jun; 165(6):854-861.e2. PubMed ID: 23708155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endogenous G-CSF and CD34+ cell mobilization after acute myocardial infarction.
    Leone AM; Rutella S; Bonanno G; Contemi AM; de Ritis DG; Giannico MB; Rebuzzi AG; Leone G; Crea F
    Int J Cardiol; 2006 Aug; 111(2):202-8. PubMed ID: 16051386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of Cardiomyocytes From Vascular Adventitia-Resident Stem Cells.
    Mekala SR; Wörsdörfer P; Bauer J; Stoll O; Wagner N; Reeh L; Loew K; Eckner G; Kwok CK; Wischmeyer E; Dickinson ME; Schulze H; Stegner D; Benndorf RA; Edenhofer F; Pfeiffer V; Kuerten S; Frantz S; Ergün S
    Circ Res; 2018 Aug; 123(6):686-699. PubMed ID: 30355234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.